Search

Your search keyword '"Liu Jien-Wei"' showing total 12 results
Start Over Author "Liu Jien-Wei" Publication Year Range Last 3 years
12 results on '"Liu Jien-Wei"'

2. Surveillance of pathogenic yeasts in hospital environments in Taiwan in 2020

Author

Tsai, De-Jiun, Hsieh, Li-Yun, Chung, Pei-Jung, Chen, Yin-Zhi, Jhou, Yi-Jyun, Tseng, Kuo-Yun, Yang, Chia-Jui, Yeh, Yen-Cheng, Lin, Seng-Yi, Shin-Jung Lee, Susan, Wu, Ting-I, Chiang, Tsung-Ta, Chou, Chien-Hsuan, Miu, Wei-Chieh, Liu, Po-Yu, Lu, Chin-Te, Lee, Yuan-Ti, Syu, Yu-Ling, Hsu, Gwo-Jong, Chen, Yee-Chun, Lee, Nan-Yao, Chen, Chang-Hua, Yang, Ching-Cheng, Wang, Lih-Shinn, Liu, Jien-Wei, Kao, Chin-Chuan, Chang, Ya-Ting, Liu, Keh-Sen, Hu, Bor-Shen, Hsu, Che-Han, Huang, Yi-Ching, and Lo, Hsiu-Jung

Published
2024
Full Text
View/download PDF

5. Genetic relatedness among azole-resistant Candida tropicalis clinical strains in Taiwan from 2014 to 2018

Author

Zhou, Zi-Li, Tseng, Kuo-Yun, Chen, Yin-Zhi, Tsai, De-Jiun, Wu, Chi-Jung, Chen, Yee-Chun, Peng, Hwei-Ling, Yang, Yun-Liang, Hsieh, Li-Yun, Chen, Chang-Hua, Hsu, Che-Han, Wang, Lih-Shinn, Cheng, Ming-Fang, Hsu, Gwo-Jong, Kao, Chin-Chuan, Hu, Bor-Shen, Lee, Yuan-Ti, Liu, Jien-Wei, Liu, Keh-Sen, Miu, Wei-Chieh, Yang, Hui-Ming, Yeh, Yen-Cheng, and Lo, Hsiu-Jung

Published
2022
Full Text
View/download PDF

6. Multicenter study on clinical outcomes and risk factors in patients with Klebsiella pneumoniae bacteremia receiving cefoperazone/sulbactam treatment

Author

Chiang, Tsung-Ta, primary, Chiang, Ming-Hsien, additional, Tang, Hung-Jen, additional, Shi, Zhi-Yuan, additional, Ho, Mao-Wang, additional, Chou, Chia-Hui, additional, Lin, Shang-Yi, additional, Lu, Po-Liang, additional, Wu, Ting-Shu, additional, Shie, Shian-Sen, additional, Liu, Jien-Wei, additional, Chang, Feng-Yee, additional, Chuang, Yin-Ching, additional, Wang, Fu-Der, additional, and Yang, Ya-Sung, additional

Published
2024
Full Text
View/download PDF

7. Efficacy of cefoperazone/sulbactam for ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and the factors associated with poor outcomes

Author

Chen, Rou-Zhen, primary, Lu, Po-Liang, additional, Yang, Tsung-Ying, additional, Lin, Shang-Yi, additional, Tang, Hung-Jen, additional, Chang, Feng-Yee, additional, Yang, Ya-Sung, additional, Chiang, Tsung-Ta, additional, Wang, Fu-Der, additional, Wu, Ting-Shu, additional, Shie, Shian-Sen, additional, Ho, Mao-Wang, additional, Liu, Jien-Wei, additional, Shi, Zhi-Yuan, additional, Chou, Chia-Hui, additional, and Chuang, Yin-Ching, additional

Published
2024
Full Text
View/download PDF

9. Increasing trend of healthcare-associated infections due to vancomycin-resistant Enterococcus faecium(VRE-fm) paralleling escalating community-acquired VRE-fm infections in a medical center implementing strict contact precautions: An epidemiologic and pathogenic genotype analysis and its implications

Author

Tang, Ya-Fen, Lin, Yin-Shiou, Su, Li-Hsiang, and Liu, Jien-Wei

Abstract

To clarify whether there were clandestine intra-hospital spreads of vancomycin-resistant Enterococcus faecium(VRE-fm) isolates that led to specific strain of VRE lingering in the hospital and/or developing outbreaks that rendered a progressively increasing trend of healthcare-associated infections due to VRE-fm (VRE-fm-HAIs).

Published
2023
Full Text
View/download PDF

10. Diabetic patients suffering dengue are at risk for development of dengue shock syndrome/severe dengue: Emphasizing the impacts of co-existing comorbidity(ies) and glycemic control on dengue severity

Author

Lee, Ing-Kit, Hsieh, Ching-Jung, Lee, Chien-Te, and Liu, Jien-Wei

Abstract

The impact of type 2 diabetes mellitus (DM2) on clinical severity of dengue has not been fully understood. We aimed to assess risk factors for dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) and severe dengue (SD) (defined based on the World Health Organization 1997 and 2009 dengue classifications), and additionally identify, among DM2 patients, who are at risk for developing DHF/DSS and severe dengue.

Published
2024
Full Text
View/download PDF

11. Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976]

Author

Jean, Shio-Shin, Lee, Wen-Sen, Yu, Kwok-Woon, Liao, Chun-Hsing, Hsu, Chin-Wan, Chang, Feng-Yi, Ko, Wen-Chien, Chen, Ray-Jade, Wu, Jiunn-Jong, Chen, Yen-Hsu, Chen, Yao-Shen, Liu, Jien-Wei, Lu, Min-Chi, Lam, Carlos, Liu, Cheng-Yi, and Hsueh, Po-Ren

Published
2024
Full Text
View/download PDF

12. Analyses of clinical and laboratory characteristics of dengue adults at their hospital presentations based on the World Health Organization clinical-phase framework: Emphasizing risk of severe dengue in the elderly

Author

Kuo, Hong-Jie, Lee, Ing-Kit, and Liu, Jien-Wei

Abstract

Dengue clinically dynamically changes over time; the World Health Organization (WHO) dengue classification framework proposed 3 dengue clinical phases—febrile (days 1–3), critical (days 4–6) and recovery (days ≥7) phases. This study aimed to better understand clinical and laboratory characteristics in adults (≥18 years) suffering dengue in different clinical phases at their hospital presentations.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results